Risk factors for fatal pneumonia: a case control study

N Deivanayagam1, K Nedunchelian, S Ramasamy

  • 1Clinical Epidemiology Unit (CEU), Institute of Child Health, Egmore, Madras.

Indian Pediatrics
|December 1, 1992
PubMed

Insights

Associated illnesses, congenital anomalies, young age, and malnutrition significantly increase the risk of death in children hospitalized with acute pneumonia. Early clinical intervention for these factors is crucial for reducing mortality.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Public Health

Background:

  • Acute pneumonia remains a leading cause of mortality in hospitalized children.
  • Identifying specific risk factors is crucial for effective clinical management and public health interventions.

Purpose of the Study:

  • To identify and quantify risk factors associated with death in children hospitalized with acute pneumonia.
  • To inform early intervention strategies aimed at reducing pediatric pneumonia mortality.

Main Methods:

  • A case-control study was conducted with 70 deceased patients (cases) and 140 recovered patients (controls).
  • Univariate and logistic regression analyses were employed to determine significant risk factors.

Main Results:

  • Associated illnesses (Odds Ratio [OR] 51.6), age under 6 months (OR 6.5), marasmic status (OR 5.8), and congenital anomalies (OR 3.8) were significant predictors of death.
  • Severe pneumonia and lobar pneumonia also showed increased odds of mortality, though not all reached statistical significance in logistic regression.

Conclusions:

  • Associated illnesses, congenital anomalies, young age (under 6 months), and marasmic status are critical risk factors for mortality in pediatric acute pneumonia.
  • Clinicians should prioritize early identification and management of these factors to improve outcomes and minimize deaths.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...